AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mivopan IV 40mg Injection

Prescription Icon
Prescription Required

Marketer

Avion Healthcare Pvt Ltd

Salt Composition

Pantoprazole (40mg)

Overview Mivopan IV 40mg Injection

Intravenous Mivopan (40mg) is a medication that suppresses gastric acid production. It's indicated for treating acid-related gastrointestinal disorders including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, providing symptomatic relief and facilitating healing. Mivopan IV is also used prophylactically against stress ulcers in critically ill patients and pre-anesthesia to reduce aspiration risks. Classified as a proton pump inhibitor (PPI), this injectable formulation is administered by a healthcare provider only when deemed more appropriate than oral administration. Dosage and treatment duration are determined by your physician based on your condition and response. Optimal treatment involves adhering to the prescribed regimen, even with rapid symptom resolution, alongside dietary modifications such as smaller, more frequent meals and avoiding caffeine, spicy, and fatty foods. Common side effects—often mild—include nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis. Persistent or bothersome side effects warrant medical attention. Prolonged use, particularly exceeding one year, may elevate the fracture risk, especially at higher doses; discuss bone health preservation strategies, such as calcium and vitamin D supplementation, with your doctor. Mivopan IV is contraindicated in individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, and those with pre-existing osteoporosis. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to its acid-stimulating effects. Refrain from operating machinery or driving if dizziness or drowsiness occurs.

Uses of Mivopan IV 40mg Injection

Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.

Major Benefits of Mivopan IV 40mg Injection:

This medication will be administered by your healthcare provider. Self-medication is not permitted.

Common Side effects of Mivopan IV 40mg Injection:

  • Diarrhea
  • Flatulence
  • Headache
  • Joint pain
  • Nausea
  • Stomach pain
  • Vomiting
  • Dizziness
  • Thrombophlebitis

How to use Mivopan IV 40mg Injection:

This medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.

How Mivopan IV 40mg Injection works:

Mivopan 40mg intravenous injection is a proton pump inhibitor that decreases gastric acid production, thereby alleviating heartburn and acid indigestion.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Mivopan IV 40mg Injection is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Mivopan 40mg IV Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible adverse effects prior to prescription. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Administering Mivopan 40mg IV injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Mivopan IV 40mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you develop symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

For patients with kidney impairment, Mivopan 40mg IV injection is considered safe and requires no dosage modification.

LiverLiverCAUTION

For individuals with severe hepatic impairment, administration of Mivopan IV 40mg Injection requires careful consideration. A modified dosage of Mivopan IV 40mg Injection may be necessary. Physician consultation is advised.

What if you forget to take Mivopan IV 40mg Injection :

Omitting a scheduled dose of Mivopan IV 40mg Injection requires contacting your physician.

Facts to Know About Mivopan IV 40mg Injection

LabelValue
Type of Compound Benzimidazole sulfinyl compound
Potential for Dependence None.
Type of Medication Stomach and intestinal
Mechanism of Action Gastric acid secretion suppressants

FAQs on Mivopan IV 40mg Injection

Intravenous Mivopan 40mg is indicated for managing peptic ulcers, reflux esophagitis, and gastroesophageal reflux disease (GERD). This injection mitigates painkiller-induced hyperacidity. Furthermore, it's employed in the treatment of Zollinger-Ellison syndrome (ZES), a condition characterized by excessive gastric acid secretion. The mechanism of action involves decreasing stomach acid production, thereby alleviating associated symptoms.
Concurrent use of antacids and Mivopan IV 40mg Injection is permissible; administer antacids at least two hours prior to or following Mivopan IV 40mg Injection.
Expect improvement within 2 to 3 days. Complete effectiveness of Mivopan IV 40mg Injection may require up to four weeks; some symptoms might persist until then.
Prolonged therapy with Mivopan IV 40mg Injection may result in weight increase, though this is uncommon. This potential side effect might stem from improved reflux symptoms leading to increased food consumption. Address any weight concerns with your physician.
Consumption of alcohol is not recommended while using Mivopan IV 40mg Injection. Although alcohol doesn't directly interfere with the injection's mechanism, it can elevate stomach acid levels, potentially exacerbating your condition.
Administering Mivopan IV 40mg Injection is optimally done one hour prior to food consumption. Dietary restrictions include avoiding meals high in fat or spice. Furthermore, abstain from beverages containing caffeine, including tea, coffee, and cola. Alcoholic beverages should also be omitted due to the potential for symptom exacerbation.
Intravenous Mivopan 40mg is typically administered for brief treatment periods. Nevertheless, in specific conditions like peptic ulcers or Zollinger-Ellison syndrome, prolonged administration might be necessary. Extended use, however, increases the potential for adverse reactions and warrants careful discussion with a physician. Always adhere to your doctor's instructions and remain under their medical guidance when using Mivopan 40mg IV injection.
Concurrent use of painkillers and Mivopan IV 40mg Injection is considered safe. Mivopan IV 40mg Injection offers protection against the gastric irritation and ulceration sometimes caused by painkillers. Mivopan IV 40mg Injection should be administered one hour prior to meals, while painkillers are typically best consumed with or following a meal to minimize stomach discomfort.
A single dose of Mivopan IV 40mg Injection might not provide adequate relief. Several doses, however, often alleviate symptoms related to heartburn, indigestion, and acid reflux. Treatment typically lasts for a short period, up to two weeks. For conditions like peptic ulcer disease and Zollinger-Ellison syndrome, longer-term use may be medically necessary. If symptoms persist after two weeks of regular use as directed, a physician should be consulted.
Extended Mivopan IV 40mg Injection use beyond three months can trigger several adverse reactions. Low blood magnesium is a primary concern, potentially causing fatigue, confusion, dizziness, tremors, and lightheadedness. Muscle spasms and irregular heart rhythms are also possible. Prolonged administration exceeding one year increases the risk of bone fractures, gastrointestinal infections, and vitamin B12 deficiency. Vitamin B12 deficiency may lead to anemia, manifesting as increased fatigue, weakness, pallor, palpitations, dyspnea, lightheadedness, dyspepsia, anorexia, flatulence, or neurological symptoms like numbness, paresthesia, and gait disturbances.
Mivopan IV 40mg Injection
39
MRP 48
18% off